PUBLISHER: The Business Research Company | PRODUCT CODE: 1662963
PUBLISHER: The Business Research Company | PRODUCT CODE: 1662963
Controlled Substance Global Market Report 2025
A controlled substance is a drug or chemical, encompassing both illicit substances and legally prescribed pharmaceuticals, whose production, possession, or usage is regulated by the government. Controlled substance medications, whether prescribed legally or involved in illicit use, have restrictions due to their potential for causing physical and mental dependence. Despite the associated risks, these medications play a crucial role in alleviating pain and managing various symptoms, thereby enhancing the quality of life for individuals.
The primary types of controlled substances and drugs include opioids, stimulants, depressants, and cannabinoids. Opioids, for example, constitute a class of drugs utilized for the treatment of moderate to severe pain. They can be either synthesized in laboratories or derived from the opium poppy plant. These substances are distributed through various channels, including hospital pharmacies, retail pharmacies, and online platforms. Their applications span pain management, treatment for sleep disorders, addressing depression and anxiety, managing seizures, handling attention deficit hyperactivity disorder (ADHD), and more.
The controlled substances market research report is one of a series of new reports from The Business Research Company that provides controlled substances market statistics, including controlled substances industry global market size, regional shares, competitors with a controlled substances market share, detailed controlled substances market segments, market trends and opportunities, and any further data you may need to thrive in the controlled substances industry. The controlled substances market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The controlled substance market size has grown strongly in recent years. It will grow from $94.86 billion in 2024 to $101.15 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to medical advancements, regulatory frameworks, rising incidence of chronic diseases, expanding pharmaceutical industry, international trade, and collaboration.
The controlled substance market size is expected to see strong growth in the next few years. It will grow to $136.51 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to precision medicine, telemedicine and remote healthcare, opioid alternatives, continued regulatory updates, increased mental health focus. Major trends in the forecast period include regulatory changes and compliance, increasing focus on drug safety and abuse prevention, advancements in drug delivery technologies, emergence of biosimilars and generic versions, integration of digital health solution.
The rising demand for medically prescribed drugs is anticipated to boost the growth of the controlled substance market in the future. Prescription drugs are intended for the treatment, cure, remediation, therapeutic intervention, or prevention of illness, and they are often classified as controlled substances. These drugs benefit the controlled substance market by improving patient outcomes and reducing unnecessary spending. For example, in September 2024, a report from the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, indicated that spending on prescription drugs rose by 8.4% in 2022, reaching $405.9 billion, compared to a 6.8% increase in 2021. Thus, the growing demand for medically prescribed drugs is driving the expansion of the controlled substance market.
The increasing prevalence of chronic diseases is anticipated to fuel the growth of the controlled substance market. Chronic diseases persist over an extended period and tend to worsen with time. Controlled substances are instrumental in managing symptoms associated with chronic conditions such as pain management, neuropsychiatric disorders, autoimmune ailments, cardiovascular issues, and inflammatory disorders. For instance, statistics from the National Library of Medicine in January 2023 forecast a 99.5% increase, reaching 142.66 million people aged 50 and above in the US with at least one chronic condition by 2050. Furthermore, as per the World Health Organization's (WHO) 2022 Highlights released in September 2022, 74% of global deaths, totaling 41 million annually, are attributed to noncommunicable diseases (NCDs) or chronic diseases. Hence, the mounting prevalence of chronic illnesses is a driving force behind the growth of the controlled substance market.
Product innovation stands out as a prominent trend gaining traction in the controlled substance market. Key players within this market are actively innovating new drugs and products to maintain their competitive edge. For instance, in January 2022, CMM (CareFlow Medicines Management Ltd.), a UK-based provider of medicine management solutions, collaborated with Modeus, a healthcare software provider based in Australia, to introduce the Controlled Drug Manager (CD Manager). This innovative platform for controlled drug management ensures the safe handling and monitoring of controlled drugs, including patient-owned medications. The newly launched CMM CD Manager, powered by Modeus, seamlessly integrates with CMM's medication management platform and other external systems. It's tailored for clinical staff and pharmacists in hospitals' pharmacy, wards, and theaters where controlled medications are stored. Through built-in reporting functionalities, CD Manager assists Controlled Drug Accountable Officers by monitoring controlled drug lifecycles within organizations and promptly addressing inconsistencies or potential diversions through automated alerts.
Major companies within the controlled substance market are driving innovation by introducing advanced technological products such as the e-module, aimed at securing a competitive advantage. The e-module stands as an online, interactive educational resource meticulously designed to ensure the appropriate availability of controlled substances for medical and scientific purposes. As an example, in September 2022, The International Narcotics Control Board (INCB), an independent treaty body based in Austria, unveiled the e-module. This initiative addresses barriers hindering the sufficient availability of essential narcotic and psychotropic substances crucial for medical treatments. The e-module offers self-paced training focused on estimating and evaluating controlled substances while covering the legal framework of drug control. It is available free of charge for government officials working within competent national authorities. Additionally, it's accessible in multiple languages including English, French, Portuguese, Russian, and Spanish, with translations provided in other languages as well.
In November 2023, Noramco, a US-based pharmaceutical manufacturing company, acquired Halo Pharmaceuticals for an undisclosed amount. This acquisition allows Noramco to broaden its service offerings by incorporating drug product formulation development, manufacturing, and packaging capabilities for its active pharmaceutical ingredient (API) customers. Halo Pharmaceuticals is also a US-based pharmaceutical manufacturing company that specializes in controlled substances.
Major companies operating in the controlled substance market include Merck & Co. Inc., Johnson and Johnson Services Inc., Orbis Biosciences Inc., GW Pharmaceuticals plc, Corium Inc., Aradigm Corporation, Alkermes plc, Sun Pharmaceutical Ltd., F. Hoffmann-La Roche Ltd., AbbVie Inc., Ampac Fine Chemicals, Siegfried Holding AG, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, Sanofi S.A., Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Teva Pharmaceutical Industries, Viatris Inc., Boehringer Ingelheim, Gilead Sciences, Amgen, Regeneron Pharmaceuticals, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Endo International, Catalent, Cambrex Corporation, Lonza Group, Indivior plc, Ipsen SA
North America was the largest region in the controlled substance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the controlled substance market report during the forecast period. The regions covered in the controlled substance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the controlled substance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The controlled substance market consists of sales of morphine, valium, ritalin, heroin, cannabis, diazepam, flunitrazepam, and ketamine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Controlled Substance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on controlled substance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for controlled substance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The controlled substance market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug: Opioids; Stimulant; Depressants; Cannabinoids
- 2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
- 3) By Application: Pain Management; Sleep Disorders; Depression And Anxiety; Seizure; Attention Deficit Hyperactivity Disorder (ADHD); Other Applications
- Subsegments:
- 1) By Opioids: Natural Opioids; Semi-Synthetic Opioids; Synthetic Opioids
- 2) By Stimulants: Amphetamines; Methylphenidate; Cocaine
- 3) By Depressants: Benzodiazepines; Barbiturates; Sleep Medications
- 4) By Cannabinoids: THC (Tetrahydrocannabinol); CBD (Cannabidiol); Synthetic Cannabinoids
- Companies Mentioned: Merck & Co. Inc.; Johnson and Johnson Services Inc.; Orbis Biosciences Inc.; GW Pharmaceuticals plc; Corium Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Controlled Substance Market Characteristics
3. Controlled Substance Market Trends And Strategies
4. Controlled Substance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Controlled Substance Growth Analysis And Strategic Analysis Framework
- 5.1. Global Controlled Substance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Controlled Substance Market Growth Rate Analysis
- 5.4. Global Controlled Substance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Controlled Substance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Controlled Substance Total Addressable Market (TAM)
6. Controlled Substance Market Segmentation
- 6.1. Global Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Opioids
- Stimulant
- Depressants
- Cannabinoids
- 6.2. Global Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- 6.3. Global Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pain Management
- Sleep Disorders
- Depression And Anxiety
- Seizure
- Attention Deficit Hyperactivity Disorder (ADHD)
- Other Applications
- 6.4. Global Controlled Substance Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Natural Opioids
- Semi-Synthetic Opioids
- Synthetic Opioids
- 6.5. Global Controlled Substance Market, Sub-Segmentation Of Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Amphetamines
- Methylphenidate
- Cocaine
- 6.6. Global Controlled Substance Market, Sub-Segmentation Of Depressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Benzodiazepines
- Barbiturates
- Sleep Medications
- 6.7. Global Controlled Substance Market, Sub-Segmentation Of Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- THC (Tetrahydrocannabinol)
- CBD (Cannabidiol)
- Synthetic Cannabinoids
7. Controlled Substance Market Regional And Country Analysis
- 7.1. Global Controlled Substance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Controlled Substance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Controlled Substance Market
- 8.1. Asia-Pacific Controlled Substance Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Controlled Substance Market
- 9.1. China Controlled Substance Market Overview
- 9.2. China Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Controlled Substance Market
- 10.1. India Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Controlled Substance Market
- 11.1. Japan Controlled Substance Market Overview
- 11.2. Japan Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Controlled Substance Market
- 12.1. Australia Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Controlled Substance Market
- 13.1. Indonesia Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Controlled Substance Market
- 14.1. South Korea Controlled Substance Market Overview
- 14.2. South Korea Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Controlled Substance Market
- 15.1. Western Europe Controlled Substance Market Overview
- 15.2. Western Europe Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Controlled Substance Market
- 16.1. UK Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Controlled Substance Market
- 17.1. Germany Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Controlled Substance Market
- 18.1. France Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Controlled Substance Market
- 19.1. Italy Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Controlled Substance Market
- 20.1. Spain Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Controlled Substance Market
- 21.1. Eastern Europe Controlled Substance Market Overview
- 21.2. Eastern Europe Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Controlled Substance Market
- 22.1. Russia Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Controlled Substance Market
- 23.1. North America Controlled Substance Market Overview
- 23.2. North America Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Controlled Substance Market
- 24.1. USA Controlled Substance Market Overview
- 24.2. USA Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Controlled Substance Market
- 25.1. Canada Controlled Substance Market Overview
- 25.2. Canada Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Controlled Substance Market
- 26.1. South America Controlled Substance Market Overview
- 26.2. South America Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Controlled Substance Market
- 27.1. Brazil Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Controlled Substance Market
- 28.1. Middle East Controlled Substance Market Overview
- 28.2. Middle East Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Controlled Substance Market
- 29.1. Africa Controlled Substance Market Overview
- 29.2. Africa Controlled Substance Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Controlled Substance Market, Segmentation By Distribution Chaneel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Controlled Substance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Controlled Substance Market Competitive Landscape And Company Profiles
- 30.1. Controlled Substance Market Competitive Landscape
- 30.2. Controlled Substance Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Orbis Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GW Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Corium Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Controlled Substance Market Other Major And Innovative Companies
- 31.1. Aradigm Corporation
- 31.2. Alkermes plc
- 31.3. Sun Pharmaceutical Ltd.
- 31.4. F. Hoffmann-La Roche Ltd.
- 31.5. AbbVie Inc.
- 31.6. Ampac Fine Chemicals
- 31.7. Siegfried Holding AG
- 31.8. Pfizer Inc.
- 31.9. Novartis AG
- 31.10. GlaxoSmithKline plc
- 31.11. Sanofi S.A.
- 31.12. Bristol-Myers Squibb
- 31.13. Eli Lilly and Company
- 31.14. AstraZeneca
- 31.15. Teva Pharmaceutical Industries
32. Global Controlled Substance Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Controlled Substance Market
34. Recent Developments In The Controlled Substance Market
35. Controlled Substance Market High Potential Countries, Segments and Strategies
- 35.1 Controlled Substance Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Controlled Substance Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Controlled Substance Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
